Cointime

Orca Bio

company

About

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

  • 101 - 250

Highlights

Total Funding Amount
$192M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series D
Last Funding Money Raised
$192M
Industries
Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2016
Number Of Employee
101 - 250
Operating Status
Active

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$192M
Orca Bio has raised a total of $192M in funding over 2 rounds. Their latest funding was raised on Jun 17, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 17, 2020 Series D $192M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Orca Bio is funded by 2 investors. Kaiser Permanente and Dream Variation Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Kaiser Permanente — Series D
Dream Variation Ventures — Series D
Cointime
เนื้อหา
บริษัท